Clinical trial
Randomized Controlled Trial Examining the Effect of Subcutaneous Xylocaine 2% on the Incidence of Vasovagal Reactions and Pain Intensity During Femoral Artery Sheath Removal.
NCT00465439 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial Examining the Effect of Subcutaneous Xylocaine 2% on the Incidence of Vasovagal Reactions and Pain Intensity During Femoral Artery Sheath Removal.
- Lead sponsor
- Hamilton Health Sciences Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- September 30, 2007
- Enrollment
- 78 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain intensity, syncope, vasovagal